Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 6 of 6 Posts
3 Cheap Pharmaceutical Stocks To Grab Now
Article By: StockNews Friday, May 28, 2021 10:17 AM EST
The pharmaceutical industry has been the beneficiary of significant investor attention amid the COVID-19 pandemic as society turned to its products to fight the coronavirus.
In this article: HLUYY, IPSEY, IRWD Also: OTSKY, EXEL, PJP, TEVA, ABBV
Read
4 Top-Ranked Drug/Biotech Stocks To Buy As Q1 Nears End
Article By: Zacks Investment Research Tuesday, March 27, 2018 8:42 AM EST
After a solid run in the first two months of the first quarter, the drug/biotech sectors struggled in March, probably on broader market pressure and a few negative updates on the pipeline and regulatory front.
In this article: GSK, LGND, HLUYY, ADVM Also: PFE, SNY, CELG
Read
4 Biotech Stocks That Show Promise On Sustainable Growth
Article By: Zacks Investment Research Friday, September 15, 2017 7:20 AM EST
Within the Medical sector, biotech stocks have performed well in the first half of the year, despite challenges like rising competition, pipeline setbacks, slowdown in growth of mature products and generic competition for certain key drugs.
In this article: SGMO, CORT, HSKA, HLUYY Also: LLY, ALXN, GILD, KITE
Read
Three Large Cap Pharma Stocks To Buy Now
Article By: Zacks Investment Research Wednesday, July 12, 2017 5:20 AM EST
While investors might think that the uncertainty of health care reform would bring volatility into the sector, we’ve actually seen healthcare stocks have a pretty decent year so far. The overall “Medical” sector is up about 11.9% year-to-date.
In this article: AZN, BAYRY, HLUYY
Read
3 Large Cap Pharma Stocks To Buy Now
Article By: Zacks Investment Research Monday, June 12, 2017 3:59 PM EST
The healthcare sector has dominated headlines this year thanks to promises from the GOP and the Trump administration related to repealing and replacing Obamacare.
In this article: SNY, BAYRY, HLUYY
Read
4 Large-Cap Drug Stocks To Buy Post Q1 Earnings
Article By: Sweta Killa Thursday, May 18, 2017 3:20 PM EST
The Medical sector is among the sectors that has consistently been recording earnings growth over the last few quarters. The sector, which had recorded earnings growth of 4.5% on revenue growth of 5.2% in Q4.
In this article: MRK, BAYRY, HLUYY, ZTS
Read
1 to 6 of 6 Posts